A landscape of sequence variants in 51 commercial antibody therapeutics
Gangling Xu, Gang Wu, Chunbo Cui, Sihan Wei, Maoqing Duan, Yongfei Cui, Yu ting Mei, Chuanfei Yu, Lan Wang · 2026
Read A landscape of sequence variants in 51 commercial antibody therapeutics by Gangling Xu, Gang Wu, Chunbo Cui, Sihan Wei, Maoqing Duan, Yongfei Cui, Yu ting Mei, Chuanfei Yu, Lan Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13628134.txt.
Description
Gangling Xu and co-authors catalog stray amino acid swaps in 51 marketed antibody drugs. These sequence variants slip in during production. They can touch safety and strength, so makers watch them closely. No one had mapped them across the whole market before.
Sensitive mass spectrometry found 3,006 variant occurrences. Over 92 percent sat at or below 0.1 percent per site. Only a handful passed 0.5 percent. Chinese products matched foreign ones. Bacteria-grown antibodies ran slightly higher at the top end. Batch consistency was excellent everywhere. The authors propose 0.2 percent per site as a practical quality line, backed by the largest dataset of its kind.
Catalog record
| CREATOR | Gangling Xu, Gang Wu, Chunbo Cui, Sihan Wei, Maoqing Duan, Yongfei Cui, Yu ting Mei, Chuanfei Yu, Lan Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |